Advertisement
UK markets close in 22 minutes
  • FTSE 100

    7,888.66
    +11.61 (+0.15%)
     
  • FTSE 250

    19,393.05
    -57.62 (-0.30%)
     
  • AIM

    744.73
    -0.56 (-0.08%)
     
  • GBP/EUR

    1.1649
    -0.0034 (-0.29%)
     
  • GBP/USD

    1.2431
    -0.0008 (-0.06%)
     
  • Bitcoin GBP

    51,825.85
    +464.93 (+0.91%)
     
  • CMC Crypto 200

    1,376.85
    +64.23 (+5.15%)
     
  • S&P 500

    5,000.95
    -10.17 (-0.20%)
     
  • DOW

    37,962.55
    +187.17 (+0.50%)
     
  • CRUDE OIL

    83.29
    +0.56 (+0.68%)
     
  • GOLD FUTURES

    2,405.20
    +7.20 (+0.30%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,748.68
    -88.72 (-0.50%)
     
  • CAC 40

    8,028.96
    +5.70 (+0.07%)
     

Mandatory Notice of Trade in IDEX Biometrics - 26 April 2021

James Allen (Jamie) Simms, CFO of IDEX Biometrics ASA, has today accepted a grant of 2,750,000 incentive subscription rights to shares in IDEX. The grant was made for no consideration. IDEX shares have ISIN NO0003070609.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 9180 0186

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices, or gain admittance to buildings with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics